Search

Displaying results 6151 - 6160 of 9322 in total
  1. Drug

    Apadoline

    go.drugbank.com/drugs/DB20043
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Apadoline is a analgesic. Apadoline has a monoisotopic molecular weight of 395.2 Da.

  2. Drug

    Edronocaine

    go.drugbank.com/drugs/DB20130
    Experimental

    The usage of the INN stem '-caine' in the name indicates that Edronocaine is a local anaesthetic. Edronocaine has a monoisotopic molecular weight of 251.19 Da.

  3. Drug

    Erizepine

    go.drugbank.com/drugs/DB20234
    Experimental

    The usage of the INN stem '-zepine' in the name indicates that Erizepine is a tricyclic compound. Erizepine has a monoisotopic molecular weight of 290.18 Da.

  4. Drug

    Tigemonam

    go.drugbank.com/drugs/DB20272
    Experimental

    The usage of the INN stem '-monam' in the name indicates that Tigemonam is a monobactam antibiotic. Tigemonam has a monoisotopic molecular weight of 437.03 Da.

  5. Drug

    Hydroxytetracaine

    go.drugbank.com/drugs/DB20319
    Experimental

    The usage of the INN stem '-caine' in the name indicates that Hydroxytetracaine is a local anaesthetic. Hydroxytetracaine has a monoisotopic molecular weight of 280.18 Da.

  6. Drug

    Alimadol

    go.drugbank.com/drugs/DB20326
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Alimadol is a analgesic. Alimadol has a monoisotopic molecular weight of 281.18 Da.

  7. Drug

    Foselutoclax

    go.drugbank.com/drugs/DB21663
    Investigational

    The usage of the INN stem '-toclax' in the name indicates that Foselutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. … Foselutoclax is under investigation in clinical trial NCT06011798 (Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)).

  8. Drug

    Upanovimab

    go.drugbank.com/drugs/DB16505
    Investigational

    Upanovimab (SCTA01) was under investigation in clinical trials (NCT04683328, NCT04644185, NCT04709328 and NCT05156645) to evaluate its safety and efficacy in patients with severe COVID-19

  9. Drug

    E1v1.11

    go.drugbank.com/drugs/DB18363
    Experimental

    E1v1.11 is an antisense oligonucleotide targeting the _SMN2_ gene which is under investigation for the treatment of spinal muscular atrophy (SMA).[L48196]

  10. Drug

    SPP1148

    go.drugbank.com/drugs/DB05203
    Experimental

    SPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.